A cutoff of PROGENSA PCA3 test of 35 resulted in sensitivity of 58% and specificity of 72% in diagnosing prostate cancer in men who had high PSA and a first negative biopsy.92 The gene discussed is KLK3; the disease is prostate carcinoma.